TARA C MITCHELL

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PHILADELPHIA, PA NPI 1982850558

General Payments — all program years on this page

$103,161.52

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 97
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $12,282.83 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $8,255.839
E.R. Squibb & Sons, L.L.C. $3,397.003
ARRAY BIOPHARMA INC $630.001

By program year

Program yearAmountRecords
2018 $21,420.1222
2019 $32,886.1534
2020 $7,845.004
2021 $8,575.005
2022 $4,060.003
2023 $16,092.4216
2024 $12,282.8313

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101313555 E.R. Squibb & Sons, L.L.C. $975.00 02/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101313581 E.R. Squibb & Sons, L.L.C. $2,076.00 07/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101313597 E.R. Squibb & Sons, L.L.C. $346.00 08/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1131340890 ARRAY BIOPHARMA INC $630.00 05/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1141800292 Merck Sharp & Dohme LLC $150.00 10/21/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141800294 Merck Sharp & Dohme LLC $5,795.00 10/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141814788 Merck Sharp & Dohme LLC $300.47 10/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141814790 Merck Sharp & Dohme LLC $240.03 10/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141814961 Merck Sharp & Dohme LLC $1,424.63 10/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141814963 Merck Sharp & Dohme LLC $240.03 10/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141814965 Merck Sharp & Dohme LLC $23.01 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141908278 Merck Sharp & Dohme LLC $34.94 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141908280 Merck Sharp & Dohme LLC $47.72 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.